On October 9, 2024, the Biomedical Innovation Research Institute of Ningbo University (hereinafter referred to as the "Institute") successfully held its third conference at Ningbo University. The meeting focused on discussing the adjustment of organizational structure and had professors and experts defend the research projects.

     The meeting was chaired by Executive Vice President Sun Jie (President of Ningbo First Hospital) and delivered an important speech. At the beginning of the meeting, Executive Vice President Sun Jie highly praised the past work status of various departments of the research institute. He said, "Our team has made significant progress in the past, thanks to the hard work and outstanding contributions of our professors." Subsequently, he conducted an in-depth review of Academician Qian Wei's "Tumor Artificial Intelligence and Molecular Detection" project. This project utilizes the latest artificial intelligence technology for tumor detection, which is expected to greatly improve the accuracy and efficiency of diagnosis.

     The meeting also reviewed the annual tripartite review projects and selected 15 outstanding projects out of 23, providing corresponding research and development funding support. Among them, Professor Mu Qitian's Research on Multi module CAR-T for Visualized Immunochemotherapy Synergetic Treatment of Lymphoma, Professor Mao Haijiao's Research on the Role and Mechanism of Self adhesive Tendon Sleeve in Repairing Achilles Tendon Defects, and Professor He Wenming's Research on the Mechanism of Leukocyte Derived Chemokine 2 Inhibiting Atherosclerosis by Regulating Macrophage Polarization won unanimous praise from experts at the meeting.

     In addition, Dr. Chen Junjie from Zhejiang Tianyuan Biotechnology Co., Ltd. (Director of Tianyuan Biotechnology IPS Cell Research Laboratory, PhD in Life Sciences from Oxford University, and world-class IPS technology expert) introduced the "Induced Pluripotent Stem Cell Cultivation Project", while Ms. Zhu Youwu, the spokesperson of the company, shared the "Precision Medical Service Innovation Cooperation Project". Both projects demonstrate Tianyuan Biotechnology's innovative capabilities and development potential in the field of biotechnology.

     The meeting also reviewed the key project "HLA Stem Cell Matching Library Technology Project" jointly initiated by Professor Zhu Yabin and Dr. Liu Guangcheng from Tianyuan Biology. This project has made significant breakthroughs in stem cell typing technology, providing strong technical support for future personalized medicine.

     At the end of the meeting, Mr. Zhu Pengcheng, Vice Dean of the Institute of Biomedical Innovation at Ningbo University and General Manager of Tianyuan Biotechnology, expressed his optimistic views on the prospects of the biotechnology industry. He said, "The biotechnology industry is in a period of rapid change, and we believe that through continuous innovation and cooperation, we can bring more benefits to human health. This conference not only showcases the research results of our institute, but also provides new ideas for our future research directions and cooperation

     Since its establishment, Ningbo University Biomedical Innovation Research Institute has been committed to promoting innovative research and achievement transformation in the field of biomedicine. The successful convening of this conference further consolidated the leading position of the research institute in this field and laid a solid foundation for future research work.